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found to reflect alterations in adrenergic nerve function that have a critical
influence on the adverse outcome of patients with congestive heart failure
(CHF). Thia alteration has been shown to be of high prognostic value in
comparison with resting hemodynamic indicaa in end-stage CHF patients.
However,the comparison with another major prognostic index, peak exercise
oxY9enuptake (peak V02), has not yet been done.
We prospectively studied 93 consecutive ambuiatoty CHF patients (age
55 + 10 years) with an ejeetion fraction <45% (mean 25 & 10). Cardiac
MIBG uptake was measured as the heart to mediastinum activity ratio on
the planar image (10-min acquisition in the chest anterior wiew) obtained 4
h after a 111to 148 MBq IV injection of 1-123MIBG (H/M, mean 133 + 21%,
normal values: 192 + 42%). Peak V02 was measured during cycla axercise
(mean 20+ 6 ml/min/kg).
During a mean follow-up of 10 + 8 months, 10 patienta died and 22 had
heart transplantation. Peak VOp (p c 0.0001) and MIBG H/M (p= 0.02) were
predictive of death or transplantation by Cox univariate analysis. Using mul-
tivariate analysis, only peak V02 predicted outcome. When transplantation
events were censored, only peak V02, normalized either by body weightorby
pradieted values, emerged as predictor of outcome (p < 0.05). Kaplan-Meier
analysis confirmed the greater prognostic value of peak VOC+
We conclude that in this population of ambulato~ CHF patients, altered
adrenergic newe function has lower prognostic value than exercise capacity.
1940-991 M~~~ardialUptake of Radiol*beledAntimY~~in
Antibody Mirrors Histopathological Fibrosis in
Experimental Aortic Regurgitation
P.Lu, S.M. Goldfine, P.Zanzonico, E.M. Herrold, N. Magid, J.S. Borer. The
New YorkHospital, Cornell Medical Centec New York,NY USA
We have previously shown that (1) exuberant myocardial fibrosis invariably
accompanies, and may cause, myocyto/ysiswhen chronic experimental aor-
tic regurgitation (eAR) leads to heart failure (CHF) and (2) myocardial uptake
of In-ill-labeled antimyosin antibody (AA) in vivo is greater in chronic eAR
than in acute eAR or normal. To validate AA uptake as an index of fibrosis
in AR, we assessed relative heart AA concentration ([% injected dosa/gm]
x body wt) vs fibrosis score (Masson’s Trichrome stain and a 100 point grid
counting system) in 30 New Zealand white rabbits (19 with surgically induced
severe AR, 11 aham-operatedhorrnal) given 1-1.5 mCl In-ill-labeled AA
Fab Fragment (Myoscint) iv. and sacrificed46 hrlaterfortissue counting and
histology. Fibrosis score in AR animals sacrificed subacutely (3-5 wks of AR;
n = 11, 0 with CHF or subnormal ejeetion fraction IEFl) was 6.6 + 4.3 vs 6.2
+ 1.8 forage matched controls (n= 5, NS); in chronic eAR animals (98-128
wks of AR; n = 8, 0 with CHF/subnormal EF) score was 8.3 + 2.7 vs 5.3 +
3.8 for age-matched controls (n= 8, p < 0.1). Among AR and age-matched
control animals, relativa heart AA concentration correlated with fibrosis score
(r= 0.8, p = 0.03) despite absence of CHF or severe fibrosis. Thus in eAR,
myocardial uptake of In-ill-labeled AA quantitatively reflects myoeardial
fibrosis, probably pathogenic for myocardial damage, even when CHF is ab-
sent; therefore, external AA imaging may permit detection of fibrosis before
Cardiacfunctional and clinical deterioration in AR.
m940100 Effects of Transmyocardial LaserRevaacularizatlon on Myocsrdial Perfusion
R.J. March, A. Ali, M. Bouzoukis, B. Klontz, J.E. Parrillo, D.G. Caralis. Rush
Medical Col@a, Chicago, IL, USA
The effaets of Tranamyocardial Laser Revascularization (TMLR) on left ven-
tricular (LV) Myocardial Perfusion (MP) have not been thoroughly examined.
16 consecutive patients (pts), ten men and six women (age range 45-78
yra, mean 64) were followed at 3,6 and 12 month intewals following TMLR.
MP studies were obtained using IV dipyridamole over 4 min with 3.5 mCi of
Thallium-201 (Tl) given 3 min later. MP imaging was done both immediately
and at 3 hours following TI infusion. Finally, 1.5 mCi of TI was given and a
third set of images was obtainad. Ail images of the LV sagmenta: anterior,
lateral, inferior, posterior and septal ware scored on a scale of O-4+ by two
independent obsewera who were blinded as to the Iasad segments (O= nl, 2+
to 3+ = moderately severa ischemia, 4+= severe ischemia). There were no
deaths, myocardial infarctions or further revascularization procedures done
on these pts during their first year of follow-up.
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MP improves during the first year after TMLR, and parallels the changes
observed in angina pectoris.
1940-101 \ Accuracy of Spiral Computed Tomography for
Identifying Internal Mammary Artary and
Saphanous Vein Bypaas Graft Patency
M,G. Engelmann, A. von Smekal, E. Kurzinger, B. Hofling, M. Reiser.
Ludwig-Maximilians Univerai~ Klinikum Grosshadem Munich, Germany
Background: Spiral computed tomography (SCT) is an particularly useful
imaging method for vascular structures, i.e. coronaty grafts. Prior investiga-
tions concentrated on evaluation of saphenous vein grafts after surgey. The
value of SCT in visualizing internal mammary bypass graft patency has not
been well studied. Hence the aim of this study was to determine the value of
high resolution SCTscanner in visualization both arterial and venous bypass
grafts two years after surgery. Methoda: Forty-nine patients (age 81.1 + 7.9
years, 45 men) who had undergone CABG procedure were examined by
SCT (Siemens Somatom plus 4) and’angiography 22.2 + 5.9 months after
surgery (n = 49). In total, 134 bypass grafts (42 IMA and 92 venous grafts)
were analyzed. With SCT contiguous data set of the heart was acquired
which allowed segmental and three-dimensional visualization of the length
of grafts. Resu/ts: The patency rate of the CABG, determined angiography
was 75.7% (IMA, n = 36/42) and 73.9% (venoue grafts n = 88/92). By SCT,
32 IMA and 64 venous grafts were diagnosed correctly as patent. Thus, the
sensitivity was 88.9% (IMA) and 94.1% (venous grafts). None of correctly
occluded venous grafts was diagnosed falsely patent by SCT (specificity
100%), where the specificity of IMA graft visualization was somewhat lower
(83.3%). The accuracy of SCT (predictive value for patency of a graft) was
86.1% (IMA) and 95.7% (venous CABG), respectively. Sensitivity, specificity
and accuracy did not differ significantly between IMA or venous grafts (p =
NS).
Conclusions: The recent generation of SCT scanner is able to assess the
coronary graft patency with high sensitivity, specificity and accuracy. Both,
saphenous vein grafts and IMA grafts can be assessed with an accuracy of
about 90%. SCT is a fast and non invaeive taehnique allowing the accurate
evaluation of graft patency in the long term,
I94O-102] Ar$thaPr$dictoraof Hard and Soft Eventa
Similar in Patiants with Stable CAD?
N. Nallamothu, E.R. Acio, S. Bala-Gupta, W. VanDecker, J. Heo,
A.E. Iskandrian. Allegheny University of the Health Sciences, Philadelphia,
PA, USA
This study examined the predictors of hard events (death and non-fatal
myoeardial infarction [Ml]) andsoftevents (late revascularization > 3months)
in 1007 pts with stable CAD who underwent coronary angiography and stress
SPECT perfusion imaging. There were 680 men and 327 women aged 61
+ 11 yeara. During a mean follow-up of 46 + 28 monthe, there were 159
hard events (67 deaths and 92 non-fatal Mls) and 195 soft events (PTCA
or CABG). Uni- and multi-variate Cox suwival analysis on important clinical,
stress, catheterization and SPECT variables identified the extent of the total
perfusion abnormality (fixed and reversible) as the best predictor of total
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events (x2 = 25, p = 0.0001) and death (X2 = 21, p = 0.001); while the
presence of ischemia (X2= 11,p= 0.001) as the best predictor of soft events.
The 4 year hard event free survival was 90% in pts with large defects and
97% in Pts with no or small defects (p = 0.01). The 4 year freedom from
revaecularization was 78% in pts with ischemia and in pts with no ischemia
(p= 0.05).
Thus, the predictors of ham’andsoftevents are different in pts with stable
CAD. The perfusion defect size, a marker of LV function, is an important
predictor of death while ischemia is a more important predictor of other
events.
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D941 140 MyocardialProstsglandinReceptors(EP3Subtype)Inhibit the Inotropic Effect of
&Adrenergic Stimulation
T. Hohlfeld, K. Schr&. hrstitut ftir Phmrna/ro/ogie,
Heinrich-Heine-Univemit4 Dusseldorf, Germany
Proateglandin receptors (EP3 subtype) have recently been identified in the
human heart. The functional role of these receptors, however, is unknown.
In order to examine cardiac EP3 receptor function, prostaglandin (PG) EI
(1 nmol/min) wee infused into the IAD of anesthetised open-chest minipigs.
Heaft rate, systolic blood pressure and regional contractile activity (sonomi-
crometric crystals, area suppliedbytheLAD) were not changedatbaseline
conditions.In contrast, PGEI markedly decreased the inotropic effect of
3 @rein isoprenaline (iv.) by 74 * 18% (n = 5, p c 0.05 vs. control).
Following pretreatment with reserpine (50 r.@kg, iv., 8 h before surgery),
PGEi was equally effective (85+ 8Y0reduction of isoprenaline-stimulatad
contractility, n = 4, p <0.05 vs. control), suggesting a postsynaptic effect
of PGE1. The EP3 receptor-selectiveagonistM&B 28.787 (1 nmol/min, i.e.)
also decreased the inotropic action of isoprenaline by a similar extent, while
butaprost (5 nmollmin, i.e., selective for EP2receptors)did not.This indicates
that myocardial EP3 receptors mediate the obsewed negative inotropic ac-
tion of PGEI. The positive inotropic action of the phosphodiesteraae inhibitor
milrinone (0.2 mgikg, iv.), but not of ouabain (10 wdkg, iv.), was also inhib-
ited by PGE1, suggesting that myocardial EP3 receptors selectively reduce
cAMP-mediatad contractile effacfe. This was confirmed by in vitro exper-
iments, ahowing an inhibition of earcolemmal membrane cAMP formation
by PGEt (ECSO= 2.5 nM). It is concluded that myocardial EP3 receptors
inhibit cAMP-mediated inotropic effects. This provides a rational explanation
of the well-established antiischemic action of endogenous and exogenous
proeteglandins.
m941 141 PulmonaryArteryBandingUpregulateeVaacularEndotheliaiGrowth Factor and ita Flkl Receptor
in Pig Haarts
S. Kuki, E.P. Bauer, M. Arras, R. Zimmerman, W. Schapar.
Mex-Planck-institute, Bad Nauheim, Germany
Although vascular endothelial growth factor (VEGF) is a potent and specific
endothelial mitogen that is able to induce angiogenesis, little is known ra-
garding the role of VEGF in in vivo cardiac hypertrophy which requires a
propcmionai coronaty artety growth. We investigated the gene expression
of VEGF and its Flkl and Fltl receptors using right ventricular hypertrophy
(RVH) after pulmonary artwy banding (PAB) in pigs, which exhibit a coronary
artery anatomy and distribution similar to humans. 35 pigs (5 groups) were
used, each group included 4 bandad (B) and 3 eham (S)-pigs. Pigs were
killed at 2h, Id, 3d, 7d, and 24d after PAB. RV/(lVS + LV) in weight was usad
for index of RVH. VEGF, Flkl, Fltl and atrial natriuretic factor (ANF) mRNA
were analyzed by Northern blot hybridization. Mean trans-banding pressure
TimeafterPAB
2h Id 3d 7d 24d
RV/(lVS+LV) 1.07 1.0 1.31 1.65** 1.63**
ANF/18S 1.12 2.42** 5.24”* 1.63 1.14
VEGF/18S 2.03”” 1,57 1,11 0.95 1.06
Flkll18S 1.56” 2.53** 1.64*” 1.04 1.18
Values(mesn)forS sraexpreseedssfold-increseeoverS. *p <0.05, ** p <0.01 vsS.
gradient was 29 mmHg. Significant RVH wae observed within the first week
after PAB.The expreeeion of ANF in RV wae transiently obsemd during the
development of RVH, but not in the established RVH. The rapid induction of
VEGF and the following persistent expression of Flkl were obsewad prior
to progression of RVH. In addition, we investigated transmural distribution of
these mRNAs at 2h after PAB, however, there were no differences in mRNAa
level between subendo&ardiurn and subepicardiurr,r.The expression of FM
could not be observed, The extremely rapid expression of the Iigand and
receptor mRNA before hypertrophy suggeet functions of the VEGF-system
in addition to angiogenesis.
[941-1~ DeWeaeeCfLeVelsof lKAc~mRhlAinPatientsvvith
Chronic Atrial Fibrillation but no Changes in the
Sercoplaamic Reticulum Calcium ATPase and
Phospholamban
B.J. Brundel, I.C. Van Gelder, R.H, Henning, L.E. Deelman,
A.E. Tuinenburg, W.H. Van Gilst, H.J. Crijns. Dept. of Cardio/ogyand
Clinical Pharmacology, Thoraxcentec fJniveraify Hoapita/ Gronirrgan, The
Natherfands
Impairment of atrial and ventricular function is an important consequence of
atrial fibrillation (AF). This maybe caused by a tachycardiomyopathy (TCM).
Nodataonthe underlying mechanism are available. The aim of this atudyisto
investigate mRNA Ievela of proteins influencing the calcium and potassium
handling, sarcoplasmic reticulum calcium ATPase (SERCA), phospholam-
ban (Pi) and one WmpOflent Ofthe iKAch,the cardiac inward rectifier (CIR).
Right atrial appendages (RAA) wera obtained from 18 patients with AF and
from 19 controls in einus rhythm who were matched for age, sex, undetfy-
ing disease, drugs and functional class.Previous duration of AF was 9 *
3 months. Total RNA of RAA was isolated and reversely transcribed into
cDNA. In a single semi-quantitative polymerase chain reaction the mRNA of
interest and of glycereldehyde-3-phosphate dehydrogenaee (GAPDH) were
coamplified and eepareted by gel-electrophoresis. cDNAa of the ethidium
bromide stained gels were quantified by densitrometry. The CIR mRNAcon-
tent was significantly reduced (–38%, p c 0.05). SERCAand PI mRNA Ievele
were unchanged. GAPDH levels were identical for both groups. Conclusion:
chronic AF did not affect mRNA levels of SERCAand P1.However, the mRNA
level of one component of IKKW (CIR) was significantly downregulated in the
RAA of patients suffering from chronic AF.
/941-143/ lnVOlvementOfJanuSkina*S (Jak)in (Jrokinass
Receptor (uPAR) Signaling - A Novel Pathway to
Alter Gene Expression in the Development of
Atherosclerosis?
A. Weis, 1.Dumler, R. Diefz, D.C. Gulba. Humboldt l/niversityat Berlin,
Berlin, Germany
The binding of urokinase-type plaeminogen activator (uPA) to cell surfacea
via its specific receptor (uPAR) facilitates migration, invasion and matrix
degradation for vascular smooth muacle cells (SMCS) and endothelial cells
(ECe)- kay events in atherosclerosis and in intimal thickening after vascular
injuty. However, the exact signaling pathwaye of the uPA/uPAR syatem are
so far unknown. This etudy proposee a role for the Jak/STAT pathway in
the uPAR-mediated signaling by providing a cloee association of the Janus
kinases Jakl and Tyk2 with the uPAR in human aortic SMCS and human
umbilical vein ECe. Cell Iysates of a primary culture of SMCe and ECSwere
immunoprecipitatad with anti-uPAR monoclinal antibodies. Precipitated pro-
teins were separated by gel electrophoreeie, transferred to a PVDF mem-
brane, immunoblottad with polyclonal anti-Jakl, anti-Jak2, anti-Jak3, and
anti-Tyk2 antibodies, and viaualizad by chemi-luminescent etaining. There
wae a close association of uPAR with Jakl and Tyk2 in both SMCe and ECS
cell Iysatee,but not with Jak2 and Jak3.
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